Category: Fundamentals Five-α-reductase inhibitors treat BPH by decreasing levels of intracellular DHT (the major growth-stimulatory hormone in prostate cells) without reducing testosterone levels. This leads to prostatic size reduction of 20% to 30%.
No comments :
Post a Comment